2019
DOI: 10.1016/j.cmet.2018.09.003
|View full text |Cite
|
Sign up to set email alerts
|

The Itaconate Pathway Is a Central Regulatory Node Linking Innate Immune Tolerance and Trained Immunity

Abstract: Sepsis involves simultaneous hyperactivation of the immune system and immune paralysis, leading to both organ dysfunction and increased susceptibility to secondary infections. Acute activation of myeloid cells induced itaconate synthesis, which subsequently mediated innate immune tolerance in human monocytes. In contrast, induction of trained immunity by b-glucan counteracted tolerance induced in a model of human endotoxemia by inhibiting the expression of immune-responsive gene 1 (IRG1), the enzyme that contr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
223
2
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 252 publications
(236 citation statements)
references
References 49 publications
3
223
2
1
Order By: Relevance
“…Of note, itaconate-induced tolerance in human monocytes is counteracted by β-glucan-induced trained immunity as β-glucan inhibits the expression of immune-responsive gene 1 (IRG1) protein, the enzyme responsible for itaconate generation. Consistent with fumarate accumulation in β-glucan-trained monocytes 131 , β-glucan-mediated inhibition of IRG1 results in elevated expression of succinate dehydrogenase 138 . Thus, β-glucan-induced trained immunity is associated with enhanced succinate dehydrogenase activity and accumulation of fumarate as well as with reversing the endotoxin tolerance-inducing effects of itaconate, which acts as an antagonist of succinate dehydrogenase.…”
Section: Active Transcriptionmentioning
confidence: 71%
“…Of note, itaconate-induced tolerance in human monocytes is counteracted by β-glucan-induced trained immunity as β-glucan inhibits the expression of immune-responsive gene 1 (IRG1) protein, the enzyme responsible for itaconate generation. Consistent with fumarate accumulation in β-glucan-trained monocytes 131 , β-glucan-mediated inhibition of IRG1 results in elevated expression of succinate dehydrogenase 138 . Thus, β-glucan-induced trained immunity is associated with enhanced succinate dehydrogenase activity and accumulation of fumarate as well as with reversing the endotoxin tolerance-inducing effects of itaconate, which acts as an antagonist of succinate dehydrogenase.…”
Section: Active Transcriptionmentioning
confidence: 71%
“…In summary, we found that PDC stimulation through pharmacologic inhibition of PDK by DCA increased TCA cycle intermediates that supply anabolic metabolites and decreased itaconate levels, a critical TCA cycle pivot for regulating the balance of immune resistance and tolerance. 54 PDC stimulation by DCA also rebalanced low levels of many amino acids and increased BCAA anaplerosis. Taken together, the monocyte cell model introduces the concept that PDC and itaconate crosstalk might couple to metabolic and immune fitness during inflammatory shock.…”
Section: Discussionmentioning
confidence: 92%
“…These findings indicate a negative feedback regulation after the activation of myeloid cells. The induction of itaconate followed by SDH inhibition also modulate the tolerance of myeloid cells and β-glucan can counteract the tolerance by inhibiting the expression of Irg1 [60].…”
Section: Krebs Cyclementioning
confidence: 99%